Antithrombotic therapy after acute myocardial infarction

Abstract

Antithrombotics are basic agents for the prevention and treatment of acute coronary syndromes. They are divided into antiplatelet and anticoagulant agents. The most important oral agents are acetylosalicylic acid, clopidogrel and warfarin. Novel antithrombotics such as prasugrel, ticagrelor, rivaroxaban and dabigatran seem to be promising. The vast majority of patients after acute myocardial infarction should be treated with aspirin plus clopidogrel for 12 months unless there is an excessive risk of bleeding or a contraindication.